To our knowledge, this is the first report concerning the role of Siah2 regulating PD-L1 protein level by K63-linked ubiquitination in CCA, and our results suggest the clinical significance of Siah2-PD-L1 axis in CCA Immunotherapy. Here, SIAH2 is linked to cholangiocarcinoma.